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National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MarylandABSTRACT The translocation of catalytic protein kinase A (cPKA) in response to cyclic-adenosine mono-phosphate (cAMP)
depends on the pattern of stimulus applied to the cell. Experiments with IBMX have shown that 1), sustained cAMP elevation is
more effective than oscillations of cAMP at getting cPKA into the nucleus; and 2), cPKA enters the nucleus by diffusion. We
constructed mathematical models of cAMP activation of cPKA and their diffusion in order to study nuclear translocation of
cPKA, and conclude that hindered diffusion of cPKA through the nuclear membrane by a rapid-binding process, but not globally
reduced diffusion, can explain the experimental data. Perturbation analysis suggests that normal physiological oscillations of
glucose would not result in nuclear translocation, but chronically high glucose that produces extended calcium plateaus and/
or chronic glucagonlike peptide-1 stimulation could result in elevated levels of nuclear cPKA.INTRODUCTIONConsuming a meal activates multiple signaling events from
neural satiation signals to chemical preparation signals,
which are greater than those in response to the same amount
of glucose supplied intravenously. The enhanced stimulus to
insulin secretion accompanying glucose delivered through
a meal is called the incretin effect (1,2).
A key signal of the incretin pathway is secretion by intes-
tinal L-cells of glucagonlike peptide-1 (GLP-1), which acts
on pancreatic b-cells on both short and long timescales to
potentiate glucose-stimulated insulin secretion. GLP-1 stim-
ulates adenylyl cyclase (AC) to produce cyclic-adenosine
monophosphate (cAMP), which activates cAMP’s down-
stream targets, exchange protein activated by cAMP
(EPAC) and protein kinase A (PKA) (3). Both EPAC and
the catalytic subunit of PKA (cPKA) increase the efficiency
of insulin granule exocytosis acutely by sensitizing the
release machinery in the cell periphery (subplasma mem-
brane) to calcium (4). On a longer timescale, cPKA addition-
ally enters the nucleus, where it activates transcription of
genes important for preservation and amplification of b-cell
mass (5,6). The rapid effects are appropriate for respond-
ing to transient increases in plasma glucose with increased
insulin secretion, whereas the slow effects are appropriate
for responding to chronic increases in glucose, which
tax the b-cell and may call for expansion of cell mass or
number.
These beneficial effects of GLP-1 on insulin secretion,
along with effects on other tissues such as the liver, pancre-
atic a-cells, and the brain, have led to a new generation of
drugs that stimulate this pathway. This pathway is stimulated
either by long-lasting (degradation-resistant) agonists of theSubmitted October 9, 2009, and accepted for publication April 14, 2010.
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0006-3495/10/07/0398/9 $2.00receptor or by inhibition of the enzyme, DPP-IV, which
degrades native GLP-1.
The main goal of this study is to understand how b-cells
distinguish between brief and maintained cAMP rises and
thus how they decide whether to engage the long- or short-
term responses. This may provide insights into the mecha-
nisms of action of GLP-1-based therapies and lead to further
improvements in that area.
We approach this question by modeling data obtained in
b-cells by Dyachok et al. (7), who showed that pulsatile
cAMP stimulus by isobutylmethylxanthine (IBMX) was
effective at raising peripheral cPKA but resulted in only
low levels of nuclear cPKA, whereas a sustained stimulus
raised nuclear cPKA. The translocation of cPKA to the
nucleus is thought to be rate-limiting for subsequent nuclear
phosphorylation events (8). DiPilato et al. (9) similarly
showed in other cell lines that cPKA kinetics in the nucleus
are much slower than at the plasma membrane (20–30 min
versus 2–3 min), despite the fact that cAMP penetrates the
nucleus rapidly. Harootunian et al. (10) argued that cPKA
entry into the nucleus is diffusive, rather than a result of
active transport or release from nuclear PKA holoen-
zyme—based in part on the insensitivity of the kinetics to
temperature.
We hypothesize that the order-of-magnitude delay in
nuclear cPKA elevation results from reduced effective
diffusion through the nuclear envelope owing to binding of
cPKA to molecules at the nuclear envelope. We hypothesize
further that this binding is very rapid, analogous to the
slowed diffusion of calcium in the cytosol and endoplasmic
reticulum by rapid buffers (11), which accounts for the
insensitivity of the kinetics to temperature. To address this
hypothesis we develop a model of cAMP/PKA signaling in
a spatially heterogeneous b-cell with subplasma membrane
(submembrane), cytosolic, and nuclear regions.doi: 10.1016/j.bpj.2010.04.043
Nuclear Translocation of cPKA 399In the next section, we discuss the components in the
signaling cascade from GLP-1 to nuclear cPKA and the
experimental techniques of Dyachok et al. (7) for visualizing
cPKA. In Modeling Methods we construct a three-compart-
ment ordinary differential equation model of the b-cell,
which is convenient for comparison with experimental data
and for analysis.
In Results, we show the main finding, i.e., that low effec-
tive diffusion across the nuclear membrane can account for
reduced nuclear translocation of cPKA under pulsatile-
versus-sustained cAMP stimulus protocols. Perturbation
analysis reveals the inverse relationship between effective
diffusion across the nuclear membrane and the period of
the cAMP stimulus protocol.FIGURE 1 Cartoon of cAMP-dependent PKA nuclear translocation.
GLP-1 activation of the GLP-1 receptor, a G-protein coupled receptor, trig-
gers adenylyl cyclase (AC)-mediated production of cAMP from ATP.
cAMP is degraded by various phosphodiesterase (PDE) isoforms. Binding
to protein kinase A (PKA) anchored to the membrane through A-kinase-
anchoring protein (AKAP) releases the catalytic subunits (cPKA) from the
regulatory subunits (rPKA). cPKA can then enter the nucleus through
nuclear pores. Dyachok et al. (7) labeled rPKA with cyan fluorescent protein
(CFP) and cPKA with yellow fluorescent protein (YFP) and independently
anchored labeled rPKA. Measuring with TIRF within 100 nm of the plasma
membrane detects cPKA separation as a reduction in the YFP signal. YFP-
tagged cPKA cannot enter the nucleus, so epifluorescence was used to
measure cPKA penetration of the nuclear membrane when cAMP was
raised. We hypothesize a rapidly buffering protein (small, dark blue dots)
that delays cPKA entry into the nucleus.EXPERIMENTAL BACKGROUND
The ability of cAMP to carry a diversity of signals is attrib-
uted to both differentiated degradation by a variety of phos-
phodiesterases (PDEs) (12) and spatial localization of targets
using scaffolding proteins such as A-kinase-anchoring pro-
teins (AKAPs) (13), sometimes in conjunction with PDEs
(14). However, the nuclear membrane serves as an addi-
tional, and critical, signal diversifier through the main
cAMP effector, cPKA, which can be active independent of
constraints by either PDE or scaffolding.
The pathway from GLP-1 interaction with the b-cell to
catalytic PKA activation is illustrated in Fig. 1. GLP-1 binds
to the GLP-1 receptor, which is coupled to the G protein, Gs.
Gs activation then causes cAMP production by adenylyl
cyclase (AC). cAMP is degraded by PDE bound within the
AKAP structure attached to AC, as well as by free PDE
and PDE bound to other structures. cAMP also binds protein
kinase A, a tetramer made up of two homodimers—i.e.,
a pair of regulator proteins (rPKA) and a pair of catalytic
monomers (cPKA). Free cPKA has multiple targets at the
plasma membrane as well as nuclear targets. Nuclear target
activation requires cPKA entry through the nuclear
membrane.
Dyachok et al. (7) used total internal reflection fluores-
cence (TIRF) and epifluorescence techniques to examine
the effect of cAMP oscillations on submembrane cPKA. In
the TIRF experiments, yellow-fluorescent protein (YFP)-
labeled cPKA separated from cyan fluorescent protein
(CFP)-labeled rPKA and diffused beyond the TIRF range
from its submembrane location. Brief pulses of IBMX,
a PDE blocker, produced rapid submembrane release of
cPKA-YFP and reduction of the YFP signal, which recov-
ered rapidly upon removal of IBMX. Because YFP-labeled
cPKA cannot enter the nucleus, a second set of experiments
was performed in which cPKA tagged with the fluorescent
biarsenical dye FlAsH was measured for nuclear transloca-
tion. Brief pulses of IBMX showed much less nuclear trans-
location than equivalent constant total IBMX, remaining at
basal levels.MODELING METHODS
In this section we develop a three-compartment model, including the compo-
nents in Fig. 1. We also construct a relationship between labeled molecular
concentrations and experimental measures for comparison with data and use
steady-state data from Dyachok et al. (7) to constrain the dynamic models.
Because we have fluorescence data only at the plasma membrane (TIRF
zone) and spatially averaged data from the epifluorescence experiments,
it is appropriate to construct a simplified model with a small number of
compartments to fit parameters. We also find that, with those parameter
values, the solutions to the full partial differential equation system rapidly
equilibrate spatially within each compartment (see Section S3 in the
Supporting Material).
Previous modeling has focused largely on short timescale activities
related to cAMP potentiation of exocytosis (15,16), and coupling of
cAMP and Ca2þ (17) in b-cells, as well as on short-term behavior of
cAMP in other cell types, such as HEK cells (18–21) and cardiac cells
(22). These studies have shown how the potent second-messenger cAMP
can localize its impact through compartmentalization.
Here we concentrate on the regulation of the nuclear signaling of cAMP
through slowing the entry of cPKA into the nucleus, even when cAMP
rapidly equilibrates throughout the cell. We model the b-cell as three
concentric shell compartments. ACs are located at the plasma membrane
embedded in the scaffolding AKAPs. AKAPs also bind G-protein coupledBiophysical Journal 99(2) 398–406
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AC upon stimulation by GLP-1. Production of cAMP activated in this
manner is thus initially localized to the submembrane region. Rapid degra-
dation of cAMP by phosphodiesterases, in part attached to AKAPs, limits
cAMP diffusion out of the submembrane space. Nearby membrane-bound
PKA holoenzymes bind cAMP, releasing cPKA subunits. Active cPKA
diffuses to phosphorylation targets in the cytosol and the nucleus.
There are three natural spatial domains of interest:
1. The boundary, which is where cAMP is produced and degraded, and
where PKA is primarily activated and TIRF measurements are made;
2. The cytosol, which is where cAMP and cPKA diffuse and react; and
3. The nucleus, which is where cPKA actively controls gene regulation
(although we only model the transport, not the signaling).cAMP generation from adenylyl cyclase
We model cAMP (a) formation as a constant production rate, AC, varied as a
parameter to represent the activation level of AC.cAMP degradation by PDE
Pyne and Furman (12) report a PDE distribution in the b-cell of 60–70%
PDE3B, 20–30% PDE4, and 14–30% PDE1, accounting for ~90% of the
PDE activity. A general expression for cAMP degradation due to PDE,
including inhibition by IBMX, is given in Rich et al. (21):
 kpde½PDE½cAMP
½cAMP þ Km

1 þ ½IBMX
KI
:
As cAMP concentration is comparable to or smaller than Km, typically >
1 mM (23), we make the linear approximation
kpdea$½cAMP;
and let the rate of anchored PDE be given by
kpdea ¼
kpde½PDE
Km

1 þ ½IBMX
KI
z

khi for IBMX off
klow for IBMX on

: (1)
This ignores the feedback from kinases on the PDE activity (24), but
captures the apparent effective release of cPKA seen in experiments.
Dyachok et al. (7) applied pulsatile IBMX (100 mM IBMX, 1 min on,
3 min off, repeated) and continuous IBMX (25 mM) stimulation, resulting
in equal average concentration. We assume that 25 mM IBMX is maximally
stimulating in that higher IBMX concentrations do not increase cAMP
release.
PDE4 is bound to AKAP (14), and as these cAMP and PDE reactions
occur at the membrane, we define a region within ~100 nm of the plasma
membrane, which corresponds to the measurement domain of the TIRF
experiments where these reactions take place. As hypothesized in Pyne
and Furman (12), we assume that IBMX-insensitive, soluble PDE8 with
a cAMP dissociation constant of Km ¼ 0.7 mM is found throughout the
cytosol and degrades cAMP at the linearized rate kpdes .
We label the boundary, cytosol, and nucleus as regions 3, 2, and 1, respec-
tively, and let V3, V2, and V1 correspond to the volumes of the boundary,
cytosol, and nuclear shells, respectively. Neglecting buffering of cAMP
by PKA during activation (but see (21)), and modeling cAMP flux out of
the submembrane region and across the nuclear membrane yields the
following equations for cAMP,
da3
dt
¼ AC kpdeaa3  kpdesa3 þ
S2Da
V3
ða2  a3Þ
rh2
; (2)Biophysical Journal 99(2) 398–406da2 S1Dn ða1  a2Þ S2Da ða2  a3Þ
dt
¼ kpdesa2 þ V2 rh1

V2 rh2
; (3)
da1
dt
¼ S1Dn
V1
ða1  a2Þ
rh1
; (4)
where rh1 ¼ ðr1 þ r2Þ=2 and rh2 ¼ ðr2 þ r3Þ=2, and r1, r2, r3 are the shell
thicknesses, and Sj is the outer surface area of the j
th shell. Both AC and
kpdea are nonzero only within the submembrane shell. The soluble PDE is
assumed to be active everywhere except in the nucleus.
Activation of PKA by cAMP
Protein kinase-A (PKA) is a holoenzyme consisting of two regulatory
subunits in a homodimer (rPKA) that bind cAMP and release two catalytic
subunits (cPKA) (25,26). We first write down the equations for native PKA
species and then for the labeled species used in the experiments. Lindskog
et al. (27) account for PKA activation with two reaction steps, using two
cAMP molecules binding at each step. We assume a simplified form of
PKA activation
rPKA þ 2 cPKA#ka
kb
PKA
where kb is the dissociation rate constant, which depends upon cAMP, kb(a).
In Section S4 in the Supporting Material we carry out a quasi-steady-state
reduction of the model of Lindskog et al. (27) for cAMP binding to PKA
and releasing cPKA to yield the following dissociation rate constant depen-
dence on cAMP:
kbðaÞ ¼ gaa2=

a2 þ K2d

: (5)
Movement of cAMP and PKA
Movement of cAMP in the cytosol is taken to be unbuffered, so the only
impediment to cAMP movement is molecular degradation by PDE. PKA
is not subject to degradation in the model, and cPKA, once unbound from
rPKA, can move throughout the cell, including into the nucleus (10). In
most of the simulations, cPKA only moves by diffusion, but Section S2 in
the Supporting Material considers the modulating effect of protein kinase
inhibitor, which exports cPKA from the nucleus.
The model for the native PKA components then is
dC3
dt
¼ S2Dc
V3
ðC2  C3Þ
rh2
 2kaC23R3 þ 2kbða3ÞðR3T  R3Þ;
(6)
dC1
dt
¼ S1DN
V1
ðC1  C2Þ
rh1
; (7)
dR3
dt
¼ kaC23R3 þ kbða3ÞðR3T  R3Þ; (8)
dR2
dt
¼ kaC22R2 þ kbða2ÞðR2T  R2Þ; (9)
where RjT is the total concentration of unbound rPKA homodimer (Rj) and
PKA holoenzyme (Pj) in the volume Vj, j ˛ {2, 3} (there is no rPKA in
the nucleus, j ¼ 1) and Cj is the free cPKA in volume Vj, j ˛ {1, 2, 3}. If
we let CT be the total concentration of cPKA within the entire volume V,
conservation requires
VCT ¼ V1C1 þ V2C2 þ V3C3 þ 2V2P2 þ 2V3P3;
TABLE 1 Reactions with labeled species
TIRF Epifluorescence
Species xh rPKA-CFP (monomer) zh cPKA-FlaSH
yh cPKA-YFP ch cPKA
Reactions rPKA þ 2z#ka
kb
PKAr2z
x þ y#ka
kb
PKAxy rPKA þ c þ z#
ka
kb
PKArcz
x þ cPKA#ka
kb
PKAxc rPKA þ z þ c#
ka
kb
PKArzc
rPKA þ 2c#ka
kb
PKAr2c
Species and reactions included to mirror the experimental conditions of
Dyachok et al. (7). Subscripts on PKA refer to rPKA native (r) or labeled
(x) and one or two bound cPKA native (c) or labeled (y). See Section S5
in the Supporting Material for the full equations.
Nuclear Translocation of cPKA 401which can be solved to eliminate C2. Conservation of rPKA is given by
VRT ¼ V2R2T þ V3R3T :
This leaves seven ordinary differential equations including the equations
for cAMP (Eqs. 2–4). Cyclic-AMP at the boundary and in the cytosol exerts
its effect through the dissociation reaction rate kb(a) (Eq. 5).
We expect significant numbers of regulatory subunits at the boundary
because of either their affinity to plasma membrane bound AKAPs or the
experimentally enhanced plasma membrane binding sequence CAAX (7).
Although rPKA may also exist in soluble form, we neglect rPKA diffusion.
The regulatory subunits are excluded from the nucleus.
The exchange of cPKA between the submembrane and cytosolic compart-
ments is proportional the diffusion coefficient, Dc. Diffusive flux across the
nuclear envelope is proportional to the local effective diffusion coefficient,
DN, which is smaller than Dc to account for the fraction of the nuclear
membrane occupied by pores.
As this does not produce sufficiently slow kinetics, we postulate in addition
rapid binding and unbinding of cPKA at the nuclear membrane by some mole-
cule, as yet unknown. If the binding is fast compared to the other timescales in
the system, we can apply the rapid buffering approximation (11) to obtain
DN ¼ s Dc
1 þ q;
q ¼ bT k
=kþ
k=kþ þ C2
2;
where k– and kþ are the backward and forward binding rates of cPKA to the
nuclear portal proteins; bT is the buffer concentration; and s ¼ 0.073 is the
proportion of the nuclear membrane that is occupied by the pores (28). To
make the rise of cPKA sufficiently slow, DN must be in the range 0.01–
0.001 mm2/s. Because we assume that Dc z 30 mm
2/s (for 41 kDa
cPKA), the buffering factor q must be in the range 200–2000. Although
we do not have a candidate for the buffering molecule, the expression for
q suggests some constraints on its properties. The most favorable condition
for achieving a large value of q is for the dissociation constant k–/kþ to be
comparable to or larger than the concentration of cPKA at the nuclear
membrane, C2. Even in this case, bT would need to be much greater than
k–/kþ. The larger C2 is, the larger bT would have to be.
This degree of buffering is strong but plausible. If we assume nuclear
envelope thickness Dr ¼ 0.1 mm and nuclear radius r ¼ 1 mm, the volume
of the shell would be
 4
3
pr2Drz1 mm3;Nuc ¼ gz1 þ eðz2 þ 2PKAr2z2 þ 2PKArcz2Þ þ r3ðz3 þ 2PKAr2z3 þ 2PKArcz3Þ
g þ e þ r3 ;
and
Cyto ¼ ðg þ eÞðz2 þ 2PKAr2z2 þ 2PKArcz2Þ þ r3ðz3 þ 2PKAr2z3 þ 2PKArcz3Þ
g þ e þ r3 ;and
qz200ðbTz200mMÞ
would correspond to ~105 molecules (or binding sites, if the molecule has
multiple binding sites), ~50 per pore. Alternatively, if the binding moleculeswere tiled over the surface of the nuclear envelope with a spacing of 10 nm,
105 molecules could be accommodated.
Comparison with experimental measurements
To compare the model with the experiments of Dyachok et al. (7), we need
to add equations for the labeled species (see Table 1). For the TIRF exper-
iments we need a measure of rPKA bound to cyan fluorescent protein (CFP)
and of cPKA bound to yellow fluorescent protein (YFP) at the boundary.
These are determined byCFP ¼ x3Tand
YFP ¼ y3 þ x3T  x3  PKAxc3;
where PKAxc3 is the labeled rPKA bounded to unlabeled cPKA in the sub-
membrane region, so the TIRF ratio ¼ CFP/YFP is given by
TIRF ratio ¼ x3T
y3 þ x3T  x3  PKAxc3
: (10)
In the epifluorescence experiments, fluorescence is obtained along the line
of light that emanates from below the cell. There is then a combination of
nuclear, cytoplasmic, and boundary fluorescence in the nuclear measure,
Nuc, and cytoplasmic and boundary fluorescence in the cytosolic measure,
Cyto. In the experimental figures the cells appear relatively flat, so we
assume the Nuc and Cyto measurements have the same total fractional
length (i.e., g þ e þ r3 – r2), where g and 3 are the fractions of nucleus
and cytosol, respectively, captured from the vertical fluorescence emission.
Based on the appearance of the cells we assume that the radius of the nucleus
is g ¼ r1 and e ¼ 1. See Fig. S1 in the Supporting Material for a graphic of
the geometry.
Nuc and Cyto then are given bywhere PKArczj ¼ PKArzcj for each j ˛ {2, 3}. The subscripts on PKA refer to
rPKA (r) bound to two labeled cPKA(2z), one each of labeled and unlabeled
cPKA (cz or zc), or two labeled cPKA (2c) in the shell j. The EPI ratio ¼
Nuc/Cyto. The parameter values are determined by fitting to the steady-state
experimental data (as described in the Supporting Material, and listed in
Table 2). The values in the table correspond to basal AC production of
1 mM/s, chosen to achieve steady-state level in the epifluorescence model
experiment within the 25 min dictated by the actual experiments.
RESULTS
Steady-state results
It is convenient to set the model to steady state to investigate
the dependence of the levels of cAMP and cPKA onBiophysical Journal 99(2) 398–406
TABLE 2 Parameters for both compartmental and spatial
models
EPI TIRF
Dc ¼ 100 mm2 s1* ka ¼ 1 mM2 s1* CT ¼ 0.017 mMy CT ¼ 0.11 mMy
DN¼ 0.01 mm2 s1y kpdes ¼ 0:01 s1* R3T ¼ 1.3 mMy R3T ¼ 1 mMy
Da ¼ 100 mm2 s1* khi ¼ 100 s1* RT ¼ 2.5 mMy RT ¼ 0.8 mMy
r1 ¼ 1.0 mmy klow ¼ 1 s1y zT ¼ 0.15 mMy yT ¼ 1.9 mMy
r2 ¼ 5.9 mmy AC ¼ 1 mM s1y X3T ¼ 4.4 mMy
r3 ¼ 0.1 mmy ga ¼ 6.0 s1y xT ¼ 1.5 mMy
Kd ¼ 0.13 mMy
*Estimated from the literature.
yFitted to the data. C
R2T
R3T
kd(a3)
kd(a2)
f(C)
VCT
C* CT
FIGURE 2 Steady-state cPKA dependence on cAMP and rPKA. The
dashed line and solid curve (extending above the dashed line at C*) are
the left- and right-hand sides of Wagner and Keizer (11), respectively.
Below the dashed line, the diagonal line and the dotted and dot-dashed
curves are the first, second, and third terms on the right-hand side of Wagner
and Keizer (11), respectively, and their sum makes up the solid curve.
402 Peercy and Shermanparameters. Inspection of Eqs. 6–8 shows that C is constant
across the compartments. Thus, we can calculate the steady
state of cAMP ai and feed that forward into the steady distri-
bution for R2 and R3 in terms of a steady, constant C ¼ C*.
Taking Eqs. 2–4 to steady state yields
a1 ¼ f2a2;
a2 ¼ f3a3;
a3 ¼ AC
kpdea þ kpdes þ S2DaV3rh2ð1  f3Þ
;
where
f2 ¼
S1Dn
V1rh1
kpdes þ S1DnV1rh1
;
f3 ¼
S2Da
V2rh2
kpdes þ S1DnV2rh1ð1  f2Þ þ
S2Da
V2rh2
:
Note that if there is no decay of cAMP in the cytosol and
nucleus (i.e., kpdes ¼ 0), then cAMP is uniform across the
three compartments,
a1 ¼ a2 ¼ a3 ¼ AC=kpdea :
Feeding forward into the rPKA Eqs. 8 and 9, we have
R2 ¼ kdða2ÞR2T
C2 þ kdða2Þ;
R3 ¼ kdða3ÞR3T
C2 þ kdða3Þ;
where kd(a) ¼ kb(a)/ka and, using the conservation of cPKA,
we get that C* solves the equation
VCT ¼ VC þ 2V2 C
2R2T
C2 þ kdða2Þ þ 2V3
C2R3T
C2 þ kdða3Þ; (11)
or C* is the solution to VCT ¼ f(C), where f(C) is the right-
hand side of Eq. 11. Because f(C) is monotonic, a unique
steady state is guaranteed. In Fig. 2, we plot VCT and f(C)
to represent, graphically, the parameter variation and its
effect on the steady state. The black square marks the inter-
section of f(C) with VCT, which is the steady-state level of
free cPKA, C*. Increasing total cPKA (CT) would raise the
black square and increase C*. For other parameters, it helpsBiophysical Journal 99(2) 398–406to look at their effects on the individual terms of Eq. 11, rep-
resented by the colored lines. Increasing total cytosolic rPKA
(R2T) would increase the second term of Eq. 11 (raise the red
curve), which would raise the black curve and shift the
square to the left (reduce C*), and similarly for R3T. If R2T
or R3T were decreased toward 0, C* would increase, ulti-
mately approaching CT (i.e., all cPKA would be free).
Increasing kd(a3), which corresponds to increasing cAMP
in the submembrane shell (Eq. 5), would shift the red curve
to the right, lowering the black curve, and moving the black
square to the right. Thus, C* would increase, as it should,
and similarly for kd(a2).Simulation of the TIRF and EPI experiments
The experiments of DiPilato et al. (9) showed that while the
submembrane and cytosol cAMP and cPKA concentrations
equilibrate to near steady-state levels within tens of seconds,
nuclear levels of cPKA evolve slowly. Dyachok et al. (7)
found that constant elevated IBMX yields high nuclear
cPKA, whereas pulsatile IBMX yields low nuclear cPKA
measured by epifluorescence. Fig. 3 A shows the basal EPI
ratio and the response to oscillating and maintained IBMX
in correspondence with the experiments of Dyachok et al.
(7) using the three-compartment model. (Note that the epi-
fluorescence experiments provided only the final values,
not a full time-course.) Fig. 3 B shows a simulation of the
TIRF measurements at the submembrane, which agree well
with the experiments. These measurements are unaffected
by the nuclear transport rates, but the EPI ratio is. The
nuclear concentrations of cPKA for varying nuclear
membrane permeabilities (DN ¼ 0.0005 mm2/s, 0.001 mm2/s,
and 0.01 mm2/s) and pulsatile IBMX stimulus are shown
in Fig. 4. As DN increases, nuclear cPKA (C1) oscillates
with increased amplitude and higher mean level. A value
of DN > 0.005mm/s and sustained stimulus will produce an
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FIGURE 3 Simulation of epifluorescence (A) and TIRF (B) experiments
of Dyachok et al. (7) in response to oscillating and maintained IBMX.
Diffusion through the nuclear membrane DN ¼ 0.01. (A) basal (dotted),
pulsatile IBMX (on for 1 min every 4 min, beginning at 3 min; solid),
and step of IBMX (on at 3 min; dashed). (B) TIRF response to pulsatile
and stepped IBMX.
0 5 10 15 20 25
0.02
0.04
0.06
0.08
0.1
0.12
0.14
t (min)
z 1
 
(mM
)
 
 
DN=0.01
DN=0.001
DN=0.0005
FIGURE 4 Effects of nuclear envelope diffusion rate for cPKA, DN, on
the labeled cPKA, z1. DN ¼ 0.0005 mm/s, 0.001 mm/s, and 0.01 mm/s for
the lower, middle, and upper curves, respectively.
Nuclear Translocation of cPKA 403EPI ratio of ~0.95 after 1500 s in agreement with Dyachok
et al. (7). Because the EPI ratio data for IBMX pulsatile stim-
ulus protocol consist of a single value taken after 1500 s, it is
difficult to compare over the range of oscillations produced
by the model. However, even the minimum of the model
oscillation in EPI ratio is ~15% over the baseline. The model
predicts that the nuclear levels of cPKA measured as a func-
tion of time, though near basal, would be slightly elevated
and oscillatory. Fig. S2 shows that those oscillations are
largely suppressed if protein kinase inhibitor is added to
the model. (Fig. S3 shows that the full spatial model gives
very similar results to the three-compartment model, vali-
dating our approximation of spatial homogeneity.)Timescale analysis
We now discuss a timescale analysis (see Section S6 in the
Supporting Material for details), which shows that the
nuclear cPKA is the slowest variable and how it depends
on the frequency of the IBMX stimulus. There are three time-
scales inherent in this system:
1. Fast: Diffusion of cAMP and cPKA.
2. Intermediate: The period of IBMX stimulation.
3. Slow: The passage of cPKA through the nuclear
envelope.
We let
d ¼ S1DN=ðV1rh1Þ
define the rate of flux across the nuclear membrane and u be
the frequency of IBMX forcing so we can rescale time in
units of stimulus period, t ¼ ut. The lowest-order approxi-
mation for C1 (from Eq. S15) is then
dC1
dt
¼ 3ðC1  cðtÞÞ; (12)
where e ¼ d/u.
Because d is proportional to the restricted diffusion coef-
ficient, DN, at the nuclear envelope, Fig. 5 shows formally
that decreasing DN reduces the variation in nuclear cPKA,
as already seen for selected simulations in Fig. 4. The inset
in the figure shows the time course of c(t), illustrating
that from the point of view of the nucleus, the cPKA signal
in the cytosol is a square wave. Note that one unit of t is one
stimulus period. The figure also shows that the amplitude of
the nuclear cPKA approaches the amplitude of the cytosolic
signal as 3 increases. If z2 were superimposed in the dimen-
sional three-compartment model simulation in Fig. 4, it
would also be a square wave, and z1 would be seen to track
z2 more faithfully as DN was increased.
Decreasing the period of stimulation with IBMX
(increasing u) would decrease 3 equivalently to decreasing
DN in the nondimensional formulation and would thusBiophysical Journal 99(2) 398–406
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404 Peercy and Shermanreduce the amplitude of nuclear cPKA oscillations. The stim-
ulus period, moreover, is experimentally accessible, so this
prediction could be tested by measuring nuclear cPKA
amplitude or perhaps the efficacy of cPKA regulation. In
Dyachok et al. (7), the stimulation by IBMX had a period
of 4 min, which corresponds to 3 ¼ 1.8.0 5 10 15 20 25
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2
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R
FIGURE 6 Functional compartmentalization of cAMP. Reducing Da to
1 mm2/s between the submembrane and cytosol compartments from the
default value of 100 mm2/s results in an overshoot of cPKA at the submem-
brane as measured by TIRF and, ironically, an increase of the peak EPI ratio
due to restricted reuptake at the submembrane.Alternatives to hindered diffusion at the nucleus
The preceding sections have shown that hindered diffusion at
the nuclear membrane could account for the delayed rise in
cPKA in the nucleus and is also compatible with the rapid
kinetics observed in Dyachok et al. (7) in the subplasma
membrane (TIRF) region. In this section we consider alterna-
tive models.
One alternative is that cAMP diffusion away from the sub-
plasma membrane region is slow. This might be expected to
limit the rise of cPKA in the cytosol, and hence, entry into
the nucleus, because free cPKA subunits diffusing in from
the periphery could be rebound to excess free rPKA.
Restricted diffusion of cAMP would not be compatible
with the data of DiPilato et al. (9) in HEK293cells showing
that the rise in nuclear cAMP is as rapid in the nucleus as at
the plasma membrane. However, in the interest of complete-
ness, we used the three-compartment model to assess the
effect of a 100-fold reduction in the diffusion coefficient
Da of cAMP in the cytosol (Fig. 6). In the compartmental
model this just amounts to a reduced flux from the boundary
region to the cytosol, but similar results would be seen with
the partial differential equation model. The TIRF ratio under
this assumption shows a sharp overshoot, resulting from
a similar overshoot in cAMP in the boundary region because
cAMP builds up faster than it can diffuse out and liberates
cPKA at a very high rate. Such an overshoot was not seen
in the experiments of Dyachok et al. (7), and because the
time resolution in those experiments was sufficiently fineBiophysical Journal 99(2) 398–406to have detected it, we conclude that in INS-1 cells, cAMP
is not compartmentalized to the point of restricting its flux
out of the submembrane region. We do not know whether
this conclusion extends to primary b-cells.
In contrast, Rich et al. (18) used a diffusion model to
propose that cAMP must be compartmentalized to explain
their observations of cAMP-activated ion channels (CNG
channels) in HEK293 cells. Specifically, their model showed
that cAMP would not rise high enough in the submembrane
space to activate the channels unless its diffusion was
restricted.
Another possible way to slow down access of cPKA to the
nucleus would be to have a small diffusion coefficient for
cPKA throughout the cytosol, not just at the nuclear
membrane. Simulations with the partial differential equation
Nuclear Translocation of cPKA 405model (not shown) in which the cytosolic diffusion coeffi-
cient is reduced confirm that this would result in a slow
rise in the nucleus, but would also produce an overshoot of
cPKA in the submembrane region because of the hindered
release of cPKA to the cytosol. This would manifest as an
overshoot in the TIRF signal similar to that in Fig. 6, and
would again not be consistent with the data in Dyachok
et al. (7). We find that we are left with no viable alternative
to hindered diffusion of cPKA at the nuclear envelope.DISCUSSION
In response to agonists that raise cAMP in pancreatic b cells,
the concentration of the catalytic subunit of Protein Kinase A
(cPKA) rises in both the cell periphery, where it potentiates
exocytosis of insulin granules, and in the nucleus, where it
acts as a regulator of gene transcription through binding to
CREB. Where cPKA appears depends on the nature of the
stimulus. We have developed here a mathematical model
to account for the experiments of Dyachok et al. (7), in which
a rapid rise was seen in cPKA at the plasma membrane in
response to both oscillatory and maintained IBMX stimuli,
although only maintained IBMX could achieve nuclear
translocation of cPKA. We confirmed that a three-compart-
ment, ordinary differential equation model was adequate
by showing with a full spatial (partial differential equation)
model that all species rapidly achieved spatial homogeneity
within the cytoplasm using the most plausible set of param-
eters (Fig. S3).
With the three-compartment model, we were able to repro-
duce the TIRF and epifluorescence experiments in Dyachok
et al. (7) by assuming reduced diffusion of cPKA through the
nuclear membrane (Fig. 3). This reduction, we propose,
results from the low-pore/nuclear-surface-area ratio but
also binding of cPKA to some unspecified molecule as it
passes through the nuclear membrane. Harootunian et al.
(10) concluded that the translocation of cPKA was not the
result of an active binding process but purely diffusive, based
in part on the insensitivity of the rate to temperature. Our
hypothesis does not contradict this conclusion, provided
that the binding is so rapid that, like the buffering of calcium,
it can be regarded as instantaneously achieving steady state.
In this case, the result of the binding is a reduced effective
diffusion constant (11) that would not be affected by varia-
tion in the binding rate, such as by changing temperature.
Temperature would then also not affect the kinetics of
cPKA. We were driven to this hypothesis because an alterna-
tive mechanism, a globally reduced diffusion constant for
cPKA, results in an overshoot of cPKA at the plasma
membrane that was not observed in the experiments.
A similar overshoot was found in the model if we assumed
reduced cAMP diffusion in the cytosol, which might also
help to localize cPKA (Fig. 6). Slow diffusion of cAMP is
moreover not compatible with the observations of DiPilato
et al. (9). Another way to localize cAMP, and hencecPKA, to the cell periphery, is via degradation by phospho-
diesterase (PDE), as shown experimentally by (22,29,29),
and in the models of Rich et al. (18,21). However, rates of
degradation that are compatible with the likely low rates of
cAMP production in b-cells and other small cells are too
low to produce a significant gradient in cAMP (see
Fig. S3). Nonetheless, in larger cells such gradients may
play a bigger role (22). Conditions under which a gradient
of cAMP would be predicted are shown in Fig. S5 and dis-
cussed further in Section S3 in the Supporting Material.
The multiple timescales in the system lend themselves to
perturbation analysis (two-timing). From this analysis we
predict that the amplitude of nuclear cPKA depends strongly
not only on the submembrane level of cPKA generated, but
also the frequency of stimulation (Fig. 5). The perturbation
analysis further predicts that nuclear cPKA would be en-
trained by the oscillatory stimulus with an amplitude that
would increase with the period of the stimulation. The model
predictions are robust to variations in the fast processes, such
as cAMP production and cPKA release, or errors in how the
model represents them, as their only role is to conspire to
produce a rise in cAMP at the nuclear envelope that is rapid
relative to the timescale of nuclear entry. As a corollary,
a critical test of the model is that the predictions should
hold for isolated nuclei as well as intact cells.
The period of IBMX stimulation in Dyachok et al. (7) was
chosen to mimic typical calcium oscillations in b-cells
because calcium activates the predominant adenylyl cyclase
isoform in b-cells, ACVIII. This period (~4 min) is too small
to result in much nuclear translocation of cPKA. In contrast,
maintained high calcium, such as would result from contin-
uous electrical spiking activity or maintained stimulation of
the glucagonlike peptide (GLP-1) receptor, would result in
significant translocation.
This would be functionally appropriate as it could be
considered a stress condition for the b-cell that would require
the activation of a nuclear response program, perhaps
enhanced cell protective mechanisms or cell proliferation.
From this point of view, one could summarize the roles of
rapidly oscillating versus maintained stimuli as follows:
Episodic challenges, such as normal meals, are met by
increasing b-cell function (increased release of insulin per
cell) through a combination of increased calcium and
increased cAMP in the periphery, which enhances the effi-
ciency of calcium-mediated exocytosis. Chronic challenges,
such as persistent overnutrition leading to hyperglycemia or
elevated fatty acids, are met through both increased function
and increased b-cell mass (larger, more robust cells or
production of new cells) triggered in part by nuclear entry
of cPKA.
We have not addressed here the stimulation of cAMP
production by calcium, but this model should dovetail with
a model of shorter term dynamics that does address the
calcium activation of both ACVIII and effectors such as
calmodulin and PDE4 (27). Fridlyand et al. (17) haveBiophysical Journal 99(2) 398–406
406 Peercy and Shermananother model using mechanisms from Yu et al. (30) that can
account for both in-phase and anti-phase oscillations of
cAMP and calcium. Combining our model with such
elements may shed further light on the functional conse-
quences of the various oscillatory patterns on a wide range
of timescales exhibited by b-cells. Finally, we suggest that,
although the details of cAMP and PKA regulation likely
differ widely among cell types, the simple mechanism
described here for distinguishing acute and chronic signals
and choosing the appropriate response may have broad
application.SUPPORTING MATERIAL
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